Abstract: The present invention provides a method of producing a crystalline metal sulfide nanostructure. The metal is a transitional metal or a Group IV metal. In the method, a porous membrane is placed between a metal precursor solution and a sulfur precursor solution. The metal cations of the metal precursor solution and sulfur ions of the sulfur precursor solution react, thereby producing a crystalline metal sulfide nanostructure.

Abstract: Antibodies that specifically bind to toxins of C. difficile, antigen binding portions thereof, and methods of making and using the antibodies and antigen binding portions thereof are provided herein.

Abstract: Embodiments of the present invention provide techniques for using data from a select set of wells to develop correlations between surface-measured properties and properties typically determined from subsurface measurements (e.g., from logging tool responses, core analysis, or other subsurface measurements). When new wells are drilled, the surface data acquired while drilling may be used as an input to these correlations in order to predict properties associated with subsurface measurements.

Abstract: Antibodies that specifically bind to toxins of C. difficile, antigen binding portions thereof, and methods of making and using the antibodies and antigen binding portions thereof are provided herein.

Abstract: A packet switched domain service processing method and device. The method is applied to a mobile terminal and includes allocating a plurality of Packet Data Protocol (PDP) link resources to a plurality of Packet Switched (PS) domain services, and using a plurality of PS domain services transmitting data on the PDP link resources allocated thereto, in order to improve data transmission rate.

Abstract: A gateway device includes a local area network (LAN) interface including a plurality of LAN ports, and a processor connected to the LAN interface. The gateway device communicates with an Internet Protocol Version 4 (IPv4) network and at least two Internet Protocol Version 6 (IPv6) networks. All the plurality of LAN ports are classified into a plurality of port groups corresponding to the at least two IPv6 networks. When an IPv6 user device is connected to any one of the plurality of LAN ports, the processor identifies the LAN port connected to the IPv6 user device, and enables the IPv6 user device to communicate with the IPv6 network corresponding to the port group which includes the LAN port connected to the IPv6 user device.

Abstract: Antibodies that specifically bind to toxins of C. difficile, antigen binding portions thereof, and methods of making and using the antibodies and antigen binding portions thereof are provided herein.

Abstract: A gateway device includes a local area network (LAN) interface including a plurality of LAN ports, and a processor connected to the LAN interface. The gateway device communicates with an Internet Protocol Version 4 (IPv4) network and at least two Internet Protocol Version 6 (IPv6) networks. All the plurality of LAN ports are classified into a plurality of port groups corresponding to the at least two IPv6 networks. When an IPv6 user device is connected to any one of the plurality of LAN ports, the processor identifies the LAN port connected to the IPv6 user device, and enables the IPv6 user device to communicate with the IPv6 network corresponding to the port group which includes the LAN port connected to the IPv6 user device.

Abstract: Antibodies that specifically bind to toxins of C. difficile, antigen binding portions thereof, and methods of making and using the antibodies and antigen binding portions thereof are provided herein.

Abstract: Antibodies that specifically bind to toxins of C. difficile, antigen binding portions thereof, and methods of making and using the antibodies and antigen binding portions thereof are provided herein.

Abstract: In a router and a method of passing IPv6 data packets through the router, the router receives a data packet from a local area network or the wide area network. The router determines if the data packet is a IPv6 data packet or a non-IPv6 data packet . The router routes the data packet to a destination address via the network layer of the open system interconnect, upon the condition that the data packet is a non-IPv6 data packet; or bridges the data packet to the destination address via the data link layer, upon the condition the data packet is a IPv6 data packet.

Abstract: Antibodies to human Cytomegalovirus (CMV) gB protein have been isolated from human B cells. The affinities of these antibodies are higher than the best previously reported antibodies. Since high affinity is critical to prevention of virus transfer across the placenta, the invention antibodies are useful as therapeutic and prophylactic agents to prevent or ameliorate effects on the fetus of CMV infection during pregnancy.

Abstract: The present invention provides a method of producing a crystalline metal sulfide nanostructure. The method comprising: providing a metal precursor solution and providing a sulfur precursor solution; placing a porous membrane between the metal precursor solution and the sulfur precursor solution, wherein metal cations of the metal precursor solution and sulfur ions of the sulfur precursor solution react, thereby producing a crystalline metal sulfide nanostructure, wherein the metal is a transitional metal or a Group IV metal.

Abstract: Antibodies that specifically bind to toxins of C. difficile, antigen binding portions thereof, and methods of making and using the antibodies and antigen binding portions thereof are provided herein.

Abstract: Antibodies that specifically bind to toxins of C. difficile, antigen binding portions thereof, and methods of making and using the antibodies and antigen binding portions thereof are provided herein.

Abstract: Antibodies that specifically bind to toxins of C. difficile, antigen binding portions thereof, and methods of making and using the antibodies and antigen binding portions thereof are provided herein.

Abstract: The present invention provides diapers with improved leak prevention, especially around the waist of the wearer. Diapers according to the invention may have a guard, for example, a leak-proof guard, to contain what is inside the diaper and thus prevent leaks that could occur without the guard. Diapers according to the invention provide added leak protection particularly on the front and backside of the baby.

Abstract: The present invention provides diapers with improved leak prevention, especially around the waist of the wearer. Diapers according to the invention may have a guard, for example, a leak-proof guard, to contain what is inside the diaper and thus prevent leaks that could occur without the guard. Diapers according to the invention provide added leak protection particularly on the front and backside of the baby.

Abstract: Antibodies that specifically bind to toxins of C. difficile, antigen binding portions thereof, and methods of making and using the antibodies and antigen binding portions thereof are provided herein.

Abstract: The present invention provides reconstituted and recombinant tissue membranes and methods for pharmaceutical delivery of bioactive molecules. In particular, reconstituted and recombinant amniotic membranes are provided for sustained delivery of therapeutic molecules, proteins or metabolites, to a site of a host in need thereof. The reconstituted and recombinant amniotic membrane contains one or more recombinant expression vectors that are exogenous to the membrane and capable of expressing bioactive molecules. The reconstituted and recombinant tissue membranes and methods can be used for in situ delivery of therapeutic proteins to a host in the treatment of disorders such as chronic wounds and dermatologic or ocular surface diseases.